Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 4,984 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

for
Breast Cancer Metastatic
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT07137871

Phase1, Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase1, Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase2, Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for
Radiographic Axial Spondyloarthritis
Location: Quebec, Trois-Rivieres, Philadelphia PA, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07133633

Phase2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase3, Recruiting

The Feasibility of Cream for Treatment of Neonatal Hypoglycemia

for
Neonatal Hypoglycemia
Location: McKinney TX
Sponsor: Baylor Research Institute

Sex: All

Age: 0

Code: NCT07217483

Recruiting

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

for
Osteoarthritis
Location: Waltham MA, Quebec, Waterbury CT, Somerset NJ, Joliette,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07153471

Phase3, Recruiting

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

for
Immunoglobulin G4 Related Disease
Location: Boston MA, Sherbrooke, Miami FL, Margate FL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07190196

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses

for
Multiple Actinic Keratoses
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06851507

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase3, Recruiting

A Study of CTD402 in T-ALL/LBL Patients

for
Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Location: The Bronx NY, New York NY, Nashville TN, Chicago IL,
Sponsor: Imviva Bio

Sex: All

Age: 1+

Code: NCT07070219

Phase1, Phase2, Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase2, Phase3, Recruiting

A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis

for
Spinal Metastasis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06906900

Phase1, Recruiting

Intent of Surgery for IPMN

for
Intraductal Papillary Mucinous Neoplasm
Location: Boston MA, New York NY, Baltimore MD, Durham NC,
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07216521

Recruiting

Caesar Foot Take-Home Validation Testing

for
Prosthesis User, Lower Limb Amputation Below Knee (Injury)
Location: Austin TX
Sponsor: Liberating Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07075198

Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

for
Non-Small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06919874

Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Philadelphia PA, Minneapolis MN, Houston TX,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase1, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas